Carotid and femoral atherosclerosis in antiphospholipid syndrome: Equivalent risk with diabetes mellitus in a case-control study.
Sign Up to like & getrecommendations! Published in 2018 at "Seminars in arthritis and rheumatism"
DOI: 10.1016/j.semarthrit.2017.10.015
Abstract: BACKGROUND Antiphospholipid syndrome (APS) may carry a worse prognosis for vascular complications when co-existing with subclinical atherosclerosis; however, the association between the two conditions remains ambiguous. METHODS We evaluated ultrasonographic markers of subclinical atherosclerosis in… read more here.
Keywords: carotid femoral; risk; antiphospholipid syndrome; sle aps ... See more keywords
Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study.
Sign Up to like & getrecommendations! Published in 2020 at "Rheumatology"
DOI: 10.1093/rheumatology/keaa321
Abstract: OBJECTIVES Evidence on comorbidity prevalence in antiphospholipid syndrome (APS) and its difference from high comorbidity burden rheumatic diseases is limited. Herein, we compare multiple comorbidities between APS and RA. METHODS A total of 326 patients… read more here.
Keywords: antiphospholipid syndrome; paps sle; sle aps; prevalence ... See more keywords
Markers of NETosis in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
Sign Up to like & getrecommendations! Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24119210
Abstract: Neutrophil Extracellular Traps (NETs) have been implicated in systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) pathogenesis. The myeloperoxidase–deoxyribonucleic acid (MPO-DNA) complex and nucleosomes are serum markers of NETosis. The aim of this study was… read more here.
Keywords: dna; sle aps; mpo dna; antiphospholipid syndrome ... See more keywords